Key result
Echocardiographic abnormalities show no significant link to mortality in hospitalized COVID-19 patients.
Why the study?
Studies focusing on cardiovascular manifestations of COVID-19 among patients from the Brazilian Legal Amazon region remain scarce.
Are echocardiographic abnormalities and cardiovascular complications associated with increased mortality in hospitalized patients with COVID-19?
Cohort (n=25)
No
Are echocardiographic abnormalities and cardiovascular complications associated with increased mortality in hospitalized patients with COVID-19?
Answers are grounded in this paper and cite their sources.
Echocardiographic abnormalities, particularly diastolic dysfunction, are highly prevalent in hospitalized COVID-19 patients and may be associated with increased mortality, though larger studies are needed to confirm statistical significance.
Background: Echocardiography plays a fundamental role in the diagnosis of cardiovascular diseases related to SARS-CoV-2 infection.Despite prior investigation in the literature, studies focusing on cardiovascular manifestations among patients from the Brazilian Legal Amazon region remain scarce.Objectives: To identify cardiovascular complications of COVID-19 in patients admitted to a hospital in the North Region of Brazil and their potential association with mortality.Methods: We conducted a retrospective cohort study including 25 medical records of adults diagnosed with COVID-19.These patients were admitted to a hospital in Belm, Par, in Northern Brazil, between March 2020 and December 2020.Demographic and clinical characteristics, as well as echocardiographic findings, were extracted from the medical records.Statistical analyses were performed adopting a significance level of < 0.05.The project was approved by the Research Ethics Committee (approval number: 5.540.025).Results: Among the 25 patients, 15 (60%) were male, with a mean age of 69.6 14.4 years.Hypertension (n = 23; 92%) was the most prevalent cardiovascular risk factor, followed by diabetes (n = 11; 44%) and obesity (n = 8; 32%).We detected echocardiographic abnormalities in 20 (80%) individuals, with diastolic dysfunction being the most frequent (n = 18; 72%).All 7 patients who died showed abnormal echocardiography (p > 0.05).Atrial fibrillation or flutter (n = 5; 20%), decompensated heart failure (n = 3; 12%), and cardiogenic shock (n = 2; 8%) were the most common types of cardiovascular involvement.Conclusions: An increasing trend in COVID-19 mortality was observed among patients with cardiovascular complications.Nevertheless, the statistical power was limited by the small sample size.
No takes yet. Share an insight, caveat, or question.
Almeida et al. (2026) conducted a cohort in COVID-19 (n=25). Abnormal echocardiogram vs. Normal echocardiogram was evaluated on Mortality (p=0.2743). Echocardiographic abnormalities were present in 80% of hospitalized COVID-19 patients, and while all deaths occurred in this group, the association with mortality was not significant.
Synapse has enriched 10 related papers. Consider them for comparative context: